Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,977,518
+$6,447,759 QoQ
Shares Held
1,032,313
-17.9% QoQ
Ownership
0.393%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#39
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $386,755,559 across 13 Drug Manufacturers - General names. OGN ranks #10 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
528,937 | $67,968,404 | |
| 2 | BIIB |
Biogen Inc.
|
279,900 | $60,475,194 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
892,969 | $51,452,873 | |
| 4 | JNJ |
Johnson & Johnson
|
200,512 | $50,924,032 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
381,851 | $48,243,055 | |
| 6 | ABBV |
AbbVie Inc.
|
108,867 | $27,395,291 | |
| 7 | LLY |
ELI LILLY & Co
|
21,971 | $26,352,678 | |
| 8 | PFE |
Pfizer Inc
|
916,205 | $22,062,216 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,977,518 | 1,032,313 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,529,759 | 1,257,055 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,027,867 | 2,653,817 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $39,657,018 | 3,713,204 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $26,189,365 | 2,705,513 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $20,849,722 | 1,400,250 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,985,444 | 803,314 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,336,980 | 801,724 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,742,250 | 712,186 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,606,659 | 670,567 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,224,737 | 501,022 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,947,276 | 169,774 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,833,213 | 328,362 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,931,061 | 294,688 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,382,446 | 192,712 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,290,978 | 55,170 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,856,735 | 84,644 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,347,911 | 124,475 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,172,859 | 104,199 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,820,552 | 177,510 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,743,585 | 123,714 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||